|By Marketwired .||
|March 27, 2014 10:20 PM EDT||
DEERFIELD, IL -- (Marketwired) -- 03/27/14 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that on March 27, 2014 the Compensation Committee of its Board of Directors approved the grant of inducement stock options to purchase an aggregate of 96,750 shares of common stock to 26 new employees.
Each stock option has an exercise price per share equal to $15.08, the fair market value on the grant date, and vests over four years, with 25% of the shares vesting on the one-year anniversary of the applicable vesting commencement date and 1/48 of the shares vesting monthly thereafter, subject to the new employee's continued service relationship with the Company. Each stock option also has a ten year term and is subject to the terms and conditions of the Company's 2011 Equity Incentive Plan and the stock option agreement pursuant to which the option was granted.
The stock options were granted as inducements material to the new employees entering into employment with Horizon Pharma in accordance with NASDAQ Listing Rule 5635(c)(4).
About Horizon Pharma
Horizon Pharma, Inc. is a commercial stage, specialty pharmaceutical company that markets DUEXIS®, VIMOVO® and RAYOS®/LODOTRA®, which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire or in-license additional innovative medicines where it can execute a targeted commercial approach among specific target physicians such as primary care physicians, orthopedic surgeons, and rheumatologists, while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit www.horizonpharma.com.
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
DevOps tends to focus on the relationship between Dev and Ops, putting an emphasis on the ops and application infrastructure. But that’s changing with microservices architectures. In her session at DevOps Summit, Lori MacVittie, Evangelist for F5 Networks, will focus on how microservices are changing the underlying architectures needed to scale, secure and deliver applications based on highly distributed (micro) services and why that means an expansion into “the network” for DevOps.
Jul. 8, 2015 04:00 AM EDT Reads: 3,183
Jul. 8, 2015 03:00 AM EDT Reads: 1,661
Jul. 8, 2015 03:00 AM EDT Reads: 884
Jul. 8, 2015 02:15 AM EDT Reads: 1,159
Jul. 8, 2015 12:00 AM EDT Reads: 2,555
Jul. 7, 2015 10:30 PM EDT Reads: 2,511
Jul. 7, 2015 10:15 PM EDT Reads: 1,280
Jul. 7, 2015 09:30 PM EDT Reads: 1,282
Jul. 7, 2015 08:00 PM EDT Reads: 1,043
Jul. 7, 2015 07:00 PM EDT Reads: 2,677
Jul. 7, 2015 07:00 PM EDT Reads: 2,649
Jul. 7, 2015 05:45 PM EDT Reads: 2,518
Jul. 7, 2015 05:00 PM EDT Reads: 2,338
Jul. 7, 2015 05:00 PM EDT Reads: 2,295
Jul. 7, 2015 04:45 PM EDT Reads: 1,764